These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24472523)

  • 21. Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas.
    Tanahashi H; Mune T; Takahashi Y; Isaji M; Suwa T; Morita H; Yamakita N; Yasuda K; Deguchi T; White PC; Takeda J
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6226-31. PubMed ID: 16118341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma.
    Nakano Y; Yoshimoto T; Watanabe R; Murakami M; Fukuda T; Saito K; Fujii Y; Akashi T; Tanaka T; Yamada T; Naruse M; Ogawa Y
    Eur J Endocrinol; 2019 Jul; 181(1):69-78. PubMed ID: 31096184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Nishimoto K
    Horm Metab Res; 2020 Jun; 52(6):421-426. PubMed ID: 32289837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
    Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.
    Ye P; Nakamura Y; Lalli E; Rainey WE
    Endocrinology; 2009 Mar; 150(3):1303-9. PubMed ID: 18974272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Heterogeneity in Aldosterone-Producing Adenomas.
    Nanba K; Chen AX; Omata K; Vinco M; Giordano TJ; Else T; Hammer GD; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):999-1007. PubMed ID: 26765578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic
    Nanba K; Blinder AR; Rege J; Hattangady NG; Else T; Liu CJ; Tomlins SA; Vats P; Kumar-Sinha C; Giordano TJ; Rainey WE
    Hypertension; 2020 Mar; 75(3):645-649. PubMed ID: 31983310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).
    Xing Y; Rainey WE; Apolzan JW; Francone OL; Harris RB; Bollag WB
    Endocrinology; 2012 Feb; 153(2):721-31. PubMed ID: 22186415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas.
    Di Dalmazi G; Morandi L; Rubin B; Pilon C; Asioli S; Vicennati V; De Leo A; Ambrosi F; Santini D; Pagotto U; Maffeis V; Fassina A; Fallo F
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32844182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma.
    Cao CX; Yang XC; Gao YX; Zhuang M; Wang KP; Sun LJ; Wang XS
    Int J Mol Med; 2012 Dec; 30(6):1396-402. PubMed ID: 23023242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
    Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
    Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.
    Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
    J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.
    Itcho K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Kobuke K; Nagano G; Yoshii Y; Baba R; Hattori N; Yoneda M
    Hypertension; 2020 Feb; 75(2):492-499. PubMed ID: 31865789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.
    Tauber P; Aichinger B; Christ C; Stindl J; Rhayem Y; Beuschlein F; Warth R; Bandulik S
    Endocrinology; 2016 Jun; 157(6):2489-99. PubMed ID: 27035656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).
    Xing Y; Cohen A; Rothblat G; Sankaranarayanan S; Weibel G; Royer L; Francone OL; Rainey WE
    Endocrinology; 2011 Mar; 152(3):751-63. PubMed ID: 21239432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells.
    Romero DG; Plonczynski MW; Gomez-Sanchez EP; Yanes LL; Gomez-Sanchez CE
    Endocrinology; 2006 Aug; 147(8):3889-97. PubMed ID: 16627589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.